TechnoDerma Medicines Inc.
Interesting news from Technoderma Medicines Inc. about their Phase 2a trial. TDM-105795: Positive Results Observed Compared to Baseline Technoderma Medicines Inc. has completed a Phase 2a clinical trial for TDM-105795, “A Randomized, Double-Blind, Vehicle Controlled, Parallel Group, Multi-Dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects with Androgenetic Alopecia.” TDM-105795 is…
This article continues the recent trend of new company announcements within the hair growth treatment industry. Even better, today’s news involves a new drug entering a phase 1 clinical trial in the US. New Drug Candidate TDM-105795 TechnoDerma Medicines Inc. of China is an early-stage biotech company based in the Zhejiang Province of China. The…